Enantioselective Total Synthesis of Griseocazine D2 & D3

10 January 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The first enantioselective and biomimetic total syntheses of neuroprotective multiprenylated pyrroloindoline-DKP Griseoca-zine D2, and its diastereomeric congener D3, are reported. The 4-step synthetic route is scalable and convergent, resulting in 24% & 32% overall yields of the congeners, respectively. One of the key features of the synthesis is the installation of both C3 and C3´ normal isoprenyl substituents through a catalytic and highly enantioselective dearomative n-isoprenylation of L-tryptophan. Use of this enantioselective strategy overrides the innate substrate selectivities and thereby requires L-tryptophan as a common precursor for both prenylation and farnesylation steps. DKP formation through the coupling of the two halves occurred without epimerization of the stereogenic alpha center of the amino acids.

Keywords

Enantioselective
First Total Synthesis
Biomimetic
Scalable
Neuroprotective agents
Prenylated pyrroloindolines
Diketopiperazine

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
This files included the comparative study of the existing method for the C3-normal prenylation process in the literature, along with the experimental methods and the analyzed spectral data.
Actions
Title
Spectra copies
Description
It includes proton NMR, carbon (proton decoupled) NMR of all synthesized fragments, as well as the final products. Along with that 2D-NMR, i.e NOESY spectral data of the final target molecules.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.